Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/13/2025 | $40.00 | Mkt Perform → Mkt Outperform | Citizens JMP |
| 4/3/2025 | $9.00 | Neutral | B. Riley Securities |
| 10/18/2024 | $11.75 | Buy | Berenberg |
| 9/19/2024 | $12.00 | Buy | Alliance Global Partners |
| 10/10/2022 | $9.00 | Outperform → Neutral | Robert W. Baird |
| 10/6/2022 | $13.00 → $9.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/7/2022 | Mkt Perform | JMP Securities | |
| 1/13/2022 | Overweight → Sector Weight | Keybanc |
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
10-Q - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
Citizens JMP upgraded Global Medical REIT from Mkt Perform to Mkt Outperform and set a new price target of $40.00
B. Riley Securities resumed coverage of Global Medical REIT with a rating of Neutral and set a new price target of $9.00
Berenberg initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $11.75
– Amends and Restates Credit Facility – – Completes One-for-Five Reverse Stock Split and Establishes $50 Million Share Repurchase Program – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced financial results for the three and nine months ended September 30, 2025 and other data. NOTE: All share and per share data have been adjusted for all periods presented to reflect the Company's one-for-five reverse stock split that was effective September 19, 2025. Third Quarter 2025 and Other Highlights Net loss attributable to common stockholders was $6.0 million, or $0.45 per diluted share, as compared to net income of $1.8 million, or $0.14 per diluted share, in th
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that it intends to release its third quarter 2025 financial results after the market closes on Tuesday, November 4, 2025. The Company intends to hold a conference call to discuss those results the following day, Wednesday, November 5, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, Chief Investment Officer Alfonzo Leon and Chief Operating Officer Danica Holley. Webcast Information Participants may access the call via live webcast by visiting the investor information section of the Company's
– Extends Loan Maturities and Enters into Forward Starting Interest Rate Swaps to Hedge Term Loans – – Weighted Average Term of the Company's Debt Increases from 1.3 Years to 4.4 Years – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that it entered into an amended and restated credit facility (the "Amended and Restated Credit Facility") that extends the maturities of its borrowings and, among other things, includes the following terms: Extends the initial maturity date of the existing $400 million revolver component of the credit facility to October 2029 with two, six-month extension options available at the Company's election to extend the maturity t
Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that Mark Decker, Jr. has been appointed as the Company's Chief Executive Officer and President, effective immediately. Mr. Decker, who will join the Board of Directors, succeeds Jeffrey Busch, who will continue to serve on the Board as non-executive Chairman. Lori Wittman, Lead Independent Director of the Company stated, "We are extremely pleased to announce Mark Decker, Jr. as our new Chief Executive Officer. As part of the Board's ongoing commitment and efforts to maximize shareholder value, we identified the need for a fresh, strategic perspective to guide our portfolio management and growth initiatives. M
Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025 Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced that as part of the Company's succession planning efforts, the Board of Directors (the "Board") has reached an agreement with Mr. Jeffrey Busch, Chairman of the Board of Directors and Chief Executive Officer ("CEO") of the Company,
– Amends and Restates Credit Facility – – Completes One-for-Five Reverse Stock Split and Establishes $50 Million Share Repurchase Program – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced financial results for the three and nine months ended September 30, 2025 and other data. NOTE: All share and per share data have been adjusted for all periods presented to reflect the Company's one-for-five reverse stock split that was effective September 19, 2025. Third Quarter 2025 and Other Highlights Net loss attributable to common stockholders was $6.0 million, or $0.45 per diluted share, as compared to net income of $1.8 million, or $0.14 per diluted share, in th
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that it intends to release its third quarter 2025 financial results after the market closes on Tuesday, November 4, 2025. The Company intends to hold a conference call to discuss those results the following day, Wednesday, November 5, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, Chief Investment Officer Alfonzo Leon and Chief Operating Officer Danica Holley. Webcast Information Participants may access the call via live webcast by visiting the investor information section of the Company's
– Extends Loan Maturities and Enters into Forward Starting Interest Rate Swaps to Hedge Term Loans – – Weighted Average Term of the Company's Debt Increases from 1.3 Years to 4.4 Years – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that it entered into an amended and restated credit facility (the "Amended and Restated Credit Facility") that extends the maturities of its borrowings and, among other things, includes the following terms: Extends the initial maturity date of the existing $400 million revolver component of the credit facility to October 2029 with two, six-month extension options available at the Company's election to extend the maturity t
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)
SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)